
ZVSA P/E Ratio
P/E Ratio as of Aug 13, 2025: -0.03
Average-0.0296
Median-0.0300
Minimum-0.0700
Maximum-0.0200
-0.03
Past Month+0.05 (62.50%)
The P/E ratio for ZVSA is -0.03 as of Aug 13, 2025. This represents a decrease of -25.00% compared to its 12-month average P/E ratio of -0.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
ZyVersa Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
ZyVersa Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing ZyVersa Therapeutics Inc to industry peers.
ZyVersa Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
ZyVersa Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing ZyVersa Therapeutics Inc to industry peers.
ZVSA P/E Ratio Insights
See ZyVersa Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ZVSA
Order type
Buy in
Order amount
Est. shares
0 shares
ZVSA P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Aug 1, 2025 | $0.1852 | -0.02 |
Jul 1, 2025 | $0.651 | -0.08 |
Jun 2, 2025 | $0.6563 | -0.08 |
May 1, 2025 | $0.619 | -0.05 |
Apr 1, 2025 | $0.5875 | -0.05 |
Mar 3, 2025 | $1.05 | -0.02 |
Feb 3, 2025 | $1.36 | -0.03 |
Jan 2, 2025 | $1.09 | -0.03 |
ZVSA End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.03 | +50.00% |
2024 | -0.02 | 0.00% |
2023 | 0.00 | -100.00% |
2022 | -1.29 | — |
FAQs About ZyVersa Therapeutics Inc (ZVSA) P/E ratio
The latest P/E ratio of ZVSA is -0.03, as of Aug 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
ZyVersa Therapeutics Inc’s last 12-month average P/E ratio is -0.04, compared to its current P/E ratio of -0.03. This reflects a decrease of -25.00%.
ZyVersa Therapeutics Inc’s current P/E ratio of -0.03 is lower than its last 12-month average P/E of -0.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
ZyVersa Therapeutics Inc’s average P/E ratio over the last 3 years is -0.32. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
ZyVersa Therapeutics Inc’s average P/E ratio over the last 5 years is -0.19. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.